Skip to main content
SpringerLink
Log in

Non-surgical Modalities of Treatment for Primary Cutaneous Cancers

  • Reference work entry
Textbook of Aging Skin

Abstract

Skin cancer, which includes melanoma and non-melanoma skin cancers (NMSCs), is the most common malignancy affecting humans [1–4]. Basal cell carcinoma (BCC) represents the most common cutaneous malignancy (comprising approximately 75% of NMSCs), followed by squamous cell carcinoma (SCC), which comprises around 20% of NMSCs [1–4]. The incidence of these cutaneous malignancies increases with age, making the elderly population most prone to the development of these cancers [1–4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 499.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tull S, Nunley K, Sengelmann R. Nonsurgical treatment modalities for primary cutaneous malignancies. Dermatol Surg. 2008;34(7):859–872.

    CAS  PubMed  Google Scholar 

  2. Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol. 2007;4(8):462–469.

    PubMed  Google Scholar 

  3. Chakrabarty A, Geisse JK. Medical therapies for non-melanoma skin cancer. Clinics in dermatology. Clin Dermatol. 2004;22(3):183–188.

    PubMed  Google Scholar 

  4. Martinez JC, Otley CC. The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. Mayo Clin Proc. 2001;76:1253–1265.

    CAS  PubMed  Google Scholar 

  5. Papadavid E, Stratigos AJ, Falagas ME. Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer. Expert Opin Pharmacother. 2007;8(11):1743–1755.

    CAS  PubMed  Google Scholar 

  6. Zagon IS, Donahue RN, Rogosnitzky M, et al. Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function. Exp Biol Med (Maywood). 2008;233(8):968–979.

    CAS  Google Scholar 

  7. Saitta P, Krishnamurthy K, Brown LH. Bleomycin in dermatology: a review of intralesional applications. Dermatol Surg. 2008;34(10):1299–1313.

    CAS  PubMed  Google Scholar 

  8. Kim KH, Yavel RM, Gross VL, et al. Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited. Dermatol Surg. 2004;30:116–120.

    PubMed  Google Scholar 

  9. Gaumann A, Schlitt HJ, Geissler EK. Immunosuppression and tumor development in organ transplant recipients: the emerging dualistic role of rapamycin. Transpl Int. 2008;21(3):207–217.

    CAS  PubMed  Google Scholar 

  10. Kuflik EG. Cryosurgery for skin cancer: 30-year experience and cure rates. Dermatol Surg. 2004;30:297–300.

    PubMed  Google Scholar 

  11. Sheridan A, Dawber R. Curettage, electrosurgery, and skin cancer. Australas J Dermatol. 2000;41:19–30.

    CAS  PubMed  Google Scholar 

  12. MacCormack MA. Photodynamic therapy in dermatology: An update on applications and outcomes. Semin Cutan Med Surg. 2008;27(1):52–62.

    CAS  PubMed  Google Scholar 

  13. Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. Br J Dermatol. 2008;159(6):1245–1266.

    CAS  PubMed  Google Scholar 

  14. Iyer S, Friedli A, Bowes L, et al. Full face laser resurfacing: Therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer. Lasers Surg Med. 2004;34:114–119.

    PubMed  Google Scholar 

  15. Hantash BM, Stewart DB, Cooper ZA, et al. Facial resurfacing for nonmelanoma skin cancer prophylaxis. Arch Dermatol. 2006;142:976–982.

    PubMed  Google Scholar 

  16. Lawrence N, Cox SE, Cockerell CJ, et al. A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol. 1995;131:176–181.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, American University of Beirut Medical Center, Beirut, Lebanon

    Ossama Abbas

  2. American University of Beirut Medical Center, Department of Dermatology, Riad El Solh St, Beirut, Lebanon, 11–0236

    Salah Salman

Authors
  1. Ossama Abbas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Salah Salman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Salah Salman .

Editor information

Editors and Affiliations

  1. The Procter & Gamble Company, 6110 Center Hill Avenue, 45224, Cincinnati, OH, USA

    Miranda A. Farage Ph.D. (Principal Scientist) (Principal Scientist)

  2. The Procter & Gamble Company, 6110 Center Hill Avenue, 45224, Cincinnati, OH, USA

    Kenneth W. Miller Ph.D. (Associate Director) (Associate Director)

  3. Department of Dermatology, University of California, School of Medicine, 222 SE 8th Ave., Suite 563, 94122, San Francisco, CA, USA

    Howard I. Maibach M.D. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Abbas, O., Salman, S. (2010). Non-surgical Modalities of Treatment for Primary Cutaneous Cancers. In: Farage, M.A., Miller, K.W., Maibach, H.I. (eds) Textbook of Aging Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-89656-2_59

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-89656-2_59

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-89655-5

  • Online ISBN: 978-3-540-89656-2

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation